Hi,
Can anybody please help me with the relevant guideline that describes the regulatory requirement for the creation of second set of MCB, in case the number of MCB vials are low in number.
Regards,
Tamal Raha
-------------------------------------------
Tamal Raha
Director, R&D and Regulatory Affairs
Chemogroup (biotech)
Madrid
Spain
-------------------------------------------